Citius Pharma (CTXR) Seeks Expeditious Pathway Into the Clinic, for CoronaVirus Related Acute Respiratory...
Sumbmits pre-IND Into Coronavirus Treatment Acceleration Program (CTAP).
Citius Announces Pre-IND Submission to FDA Under the Coronavirus...
Adding iBIO (IBIO) $2.27 to CoronaVirus Watch List.
SUPERBUG NEWS: Is this the next Robinhood target?
"Don't get ready, don't aim - just fire." Sal the...
New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and Candida Auris News.
Announces Mino-lok® Erdicates the Deadly and Untreatable C. Auris Bacteria.Announces License of Treatment for CoronaVirus Respiratory Failure.
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or...
Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial
PHASE III PROGRESS
October 7th, 2019, Citius Completes 40% - Triggers Data Being Analyzed (is it working?).December 19th, 2019...
Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.
Added to Watch List November 2019 @$0.55.
Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...
Shorts Set $1.00 Price Target on Inovio (INO) $9.20.
Interesting battle brewing!
LIVE CHART
Inovio shares tumble 8%...
Let’s be ‘Corona Clever’ and Catch one Before the POP. Athersys (ATHX) $1.85
It's a bit of a stretch...
Okay, it's a bit of a stretch,...
Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior Vice President of...
PITTSFORD, N.Y., Nov. 12, 2020
PITTSFORD, N.Y. , Nov. 12, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization...
Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.
Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.
Citius Pharma (CTXR) Inches Closer to the Next Phase...